Phantom Neuro CEO Connor Glass reviews its sensor system with Michael Easy, the first patient in the clinical trial. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results